Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07309835 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Improving Genetic Medicine for Ethnic Minority Groups

StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Lead sponsor: Guy's and St Thomas' NHS Foundation Trust to Guy's and St Thomas' NHS Foundation Trust Show 8 more changesShow less
    • Primary endpoints: details revised at 1 of 1 entry
    • Completed without a posted recruiting period
    • Final enrollment: 10 participants (planned 100)
    • Primary completion date changed from estimate of Jan 30, 2031 to Sep 30, 2026
    • Start date changed from estimate of Jan 30, 2026 to Mar 17, 2026
    • Site details revised
    • Eligibility criteria expanded, about 5 words
    • Study description expanded, about 2 words
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A key aim of the nationally commissioned Genomic Medicine Service (GMS) in England is to encourage equity of access between different patient groups, however, there is evidence to suggest that it is being under-utilised by ethnic minority groups. The aim of this study is to explore how ethnic minority populations interact with the GMS and to identify changes that would promote equity within those services. This is a mixed-methods study using interviews and group discussions with lay people, community organisers and charity workers, people who have had direct or indirect contact with the genomic medicine service and professionals within the service. By including potential service users, service users and professionals in this work and allowing people to share their experiences in whatever method feels most comfortable to them, the investigators aim to get a broad understanding of the lived experience of everyone involved in these pathways which will be key to gaining a holistic understanding of how they are working in real world settings. The primary outcome measure will be an increased understanding of the experiences of people from ethnic minority groups navigating the genomic medicine space. The secondary outcome measure will be an increased understanding of how experiences differ across and between ethnic groups. The investigators intend to use our insights to recommend structural changes which will improve utilisation of the genomic medicine service by patients from ethnic minority groups.
Trial Details
NCT Number NCT07309835
Lead Sponsor Guy's and St Thomas' NHS Foundation Trust
Conditions
(from sponsor)
Genetic Testing
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov